Panama vs Turkmenistan: Cause of death, by non-communicable diseases, female
Panama
73.7%
in 2021
Turkmenistan
74.0%
in 2021
Panama rank
71st
Turkmenistan rank
69th
Cause of death, by non-communicable diseases, female over time
- Panama
- Turkmenistan
How they compare
Turkmenistan currently reports 74.0% against 73.7% in Panama, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Panama ahead.
Panama ranks 71st and Turkmenistan ranks 69th of 185 countries.
Across the 3 decades both report, Panama averaged higher in 2 and Turkmenistan in 1.
Head to head by decade
| Decade | Panama | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 75.1% | 70.7% | 4.4% | Panama |
| 2010s | 81.5% | 75.1% | 6.4% | Panama |
| 2020s | 71.3% | 72.8% | 1.5% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Panama or Turkmenistan?
- Turkmenistan, at 74.0% against 73.7% in Panama as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Panama and Turkmenistan?
- 0.3%, with Turkmenistan ahead.
- How many years of comparable data are there for Panama and Turkmenistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Panama and Turkmenistan rank globally for cause of death, by non-communicable diseases, female?
- Panama ranks 71st and Turkmenistan ranks 69th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.